Award

ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE

BUSINESS ENERGY AND INDUSTRIAL STRATEGY

This public procurement record has 3 releases in its history.

AwardUpdate

28 Oct 2021 at 13:38

Award Notice
AwardUpdate

09 Apr 2021 at 13:55

Award Notice
Award

12 Feb 2021 at 17:50

Award Notice
Summary of the contracting process

The procurement process for the "Advance Purchase Agreement for SARS-CoV-2/COVID-19 Vaccine" was initiated by the Business Energy and Industrial Strategy in the United Kingdom. The tender, classified under the CPV code for vaccines, was completed on 14 January 2021. It was procured through a direct method, specifically a single tender action below the threshold, with a contract start date of 15 January 2021 and an end date set for 31 December 2021, although it is subject to variable conditions based on production and delivery requirements.

This tender presents significant opportunities for businesses involved in the pharmaceutical and vaccine development sectors, particularly those with innovative capabilities in vaccine production. Companies that are established suppliers of medical products or those with the capability to scale operations quickly may find potential for growth in collaboration or competition with the awarded supplier, Janssen Pharmaceutica NV, which has experience in large-scale vaccine development and distribution.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE

Notice Description

Procurement of Janssen's vaccine candidate Ad26.COV2-S.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-a729a261-0c43-4942-b8c2-b7e6cff79857
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/c97f8992-b918-4973-9e38-9eb42e6f73a8
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Single tender action (below threshold)
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651600 - Vaccines

Notice Value(s)

Tender Value
£1
Lots Value
Not specified
Awards Value
£1
Contracts Value
Not specified

Notice Dates

Publication Date
28 Oct 20214 years ago
Submission Deadline
14 Jan 2021Expired
Future Notice Date
Not specified
Award Date
15 Jan 20215 years ago
Contract Period
15 Jan 2021 - 31 Dec 2021 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
BUSINESS ENERGY AND INDUSTRIAL STRATEGY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SW1H 0ET
Post Town
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI35 Westminster and City of London
Delivery Location
Not specified
Local Authority
Westminster
Electoral Ward
St James's
Westminster Constituency
Cities of London and Westminster

Supplier Information

Number of Suppliers
1
Supplier Name

JANSSEN PHARMACEUTICA

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-a729a261-0c43-4942-b8c2-b7e6cff79857-2021-10-28T14:38:01+01:00",
    "date": "2021-10-28T14:38:01+01:00",
    "ocid": "ocds-b5fd17-a729a261-0c43-4942-b8c2-b7e6cff79857",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "4846/01/2021",
        "title": "ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE",
        "description": "Procurement of Janssen's vaccine candidate Ad26.COV2-S.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33651600",
            "description": "Vaccines"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "United Kingdom"
                    },
                    {
                        "countryName": "United Kingdom"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 1,
            "currency": "GBP"
        },
        "procurementMethod": "direct",
        "procurementMethodDetails": "Single tender action (below threshold)",
        "tenderPeriod": {
            "endDate": "2021-01-14T23:59:00Z"
        },
        "contractPeriod": {
            "startDate": "2021-01-15T00:00:00Z",
            "endDate": "2021-12-31T23:59:59Z"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/57hG7nME",
            "name": "Business Energy and Industrial Strategy",
            "identifier": {
                "legalName": "Business Energy and Industrial Strategy",
                "scheme": "GB-SRS",
                "id": "sid4gov.cabinetoffice.gov.uk/57hG7nME"
            },
            "address": {
                "streetAddress": "1 Victoria Street",
                "locality": "London",
                "postalCode": "SW1H0ET",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "VTFContracts@beis.gov.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-187449",
            "name": "JANSSEN PHARMACEUTICA NV",
            "identifier": {
                "legalName": "JANSSEN PHARMACEUTICA NV"
            },
            "address": {
                "streetAddress": "30 Turnhoutseweg B-2340 Beerse Belgium"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-SRS-sid4gov.cabinetoffice.gov.uk/57hG7nME",
        "name": "Business Energy and Industrial Strategy"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-a729a261-0c43-4942-b8c2-b7e6cff79857-1",
            "status": "active",
            "date": "2021-01-15T00:00:00Z",
            "datePublished": "2021-02-12T17:50:29Z",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-187449",
                    "name": "JANSSEN PHARMACEUTICA NV"
                }
            ],
            "contractPeriod": {
                "startDate": "2021-01-15T00:00:00Z",
                "endDate": "2021-12-31T23:59:59Z"
            },
            "description": "Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors . Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. This information is also being withheld on due to commercial sensitivity under Regulation 50(6)(b) and (c) as there is significant competition to develop and bring to the market a successful vaccine. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market.",
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/c97f8992-b918-4973-9e38-9eb42e6f73a8",
                    "datePublished": "2021-02-12T17:50:29Z",
                    "format": "text/html",
                    "language": "en",
                    "dateModified": "2021-10-28T14:38:01+01:00"
                },
                {
                    "id": "2",
                    "documentType": "contractSigned",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/SupplierAttachment/5dabc54e-5f41-4d37-8dfd-968dc0a98f6f",
                    "format": "application/pdf"
                },
                {
                    "id": "3",
                    "documentType": "contractSigned",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/SupplierAttachment/10d8530a-48a6-42de-982b-e1c8618aa877",
                    "format": "application/pdf"
                }
            ]
        }
    ]
}